Shares Held (Direct Ownership) 3.53M
232.66% 3M change
232.66% 12M change
Total Value Held N/A

Erez Aminov Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2025
BUY
Grant, award, or other acquisition
-
2,685,456 Added 43.21%
3,530,156 Common Stock
Aug 29 2025
BUY
Grant, award, or other acquisition
$85,625 $1.37 p/Share
62,500 Added 6.89%
844,700 Common Stock
Nov 20 2024
SELL
Open market or private sale
$56,629 $1.27 p/Share
44,590 Reduced 4.03%
1,061,200 Common Stock
Nov 19 2024
SELL
Open market or private sale
$77,019 $1.39 p/Share
55,410 Reduced 4.77%
1,105,790 Common Stock
May 21 2024
BUY
Open market or private purchase
$8,265 $0.95 p/Share
8,700 Added 2.23%
382,200 Common Stock

Also insider at

TELO
Telomir Pharmaceuticals, Inc.
EA

Erez Aminov

Chief Executive Officer
Baltimore, MD

Track Institutional and Insider Activities on MIRA

Follow MIRA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRA shares.

Notify only if

Insider Trading

Get notified when an Mira Pharmaceuticals, Inc. insider buys or sells MIRA shares.

Notify only if

News

Receive news related to MIRA PHARMACEUTICALS, INC.

Track Activities on MIRA